SFS
ATRS

Sowell Financial Services’s Antares Pharma, Inc. ATRS Stock Holding History

Sowell Financial Services’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,231
Closed -$4K – 3093
2021
Q1 		$4K Buy
+1,231
New +$5.33K ﹤0.01% 2701

Other funds holding ATRS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return
Amundi
Amundi Paris, France $416B AUM 44.19% 1-Year Est. Return

Sowell Financial Services's ATRS Position: Q2 2021 in Review

Sowell Financial Services sold out of Antares Pharma, Inc. (ATRS) in Q2 2021, closing a stake of 1,231 shares — an estimated $4K sold.

Sowell Financial Services first reported a position in ATRS in Q1 2021 and held it in 1 quarter. The position peaked at $4K in Q1 2021. 175 funds tracked by Wall St. Rank hold ATRS as of Q2 2021.

  • Sowell Financial Services reported no remaining Antares Pharma, Inc. position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 1,231 Antares Pharma, Inc. shares in Q2 2021, an estimated $4K.
  • Sowell Financial Services first reported a position in Antares Pharma, Inc. in Q1 2021 and held it in 1 quarter.
  • Sowell Financial Services's Antares Pharma, Inc. position peaked at $4K in Q1 2021.
  • 175 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.